The Experts below are selected from a list of 360 Experts worldwide ranked by ideXlab platform
Peter C Appelbaum - One of the best experts on this subject based on the ideXlab platform.
-
activity of dx 619 compared to other agents against viridans group streptococci streptococcus bovis and Cardiobacterium hominis
Antimicrobial Agents and Chemotherapy, 2006Co-Authors: Klaudia Kosowskashick, Kathy Smith, Tatiana Bogdanovich, Lois M Ednie, Ronald N Jones, Peter C AppelbaumAbstract:Against 198 viridans group streptococci, 25 Streptococcus bovis strains, and 5 Cardiobacterium hominis strains, MICs of DX-619, a des-F(6)-quinolone, were between 0.004 and 0.25 microg/ml. These MICs were lower than those of other quinolones ( 32 microg/ml). Beta-lactam MICs were between < or = 0.008 and 16 microg/ml. Azithromycin resistance was found in most species, while most were telithromycin susceptible. Glycopeptides and linezolid were active against viridans group strains but inactive against C. hominis.
Essia Boughzela - One of the best experts on this subject based on the ideXlab platform.
-
a pediatric case of Cardiobacterium hominis endocarditis after right ventricular outflow tract reconstruction
Journal of Infectious Diseases and Therapy, 2015Co-Authors: Mehdi Slim, R Gribaa, Elies Neffati, Sana Ouali, F Remadi, Essia BoughzelaAbstract:Cardiobacterium hominis, a member of the HACEK group of organisms, is a rare cause of endocarditis and is even rarer in pediatric population. In this report, we present a case of infective endocarditis caused by C. hominis in a 16-year-old Tunisian girl who had undergone right ventricular outflow tract reconstruction using a Hancock® heterograft for double outlet right ventricle with pulmonary stenosis. Two weeks before admission, the patient suffered from worsened shortness of breath and fever. Tranthoracic echocardiography revealed right ventricular outflow tract stenosis and vegetation attached to the leaflet conduit. The Subsequent blood cultures grew Cardiobacterium hominis and the patient was treated successfully with 6 weeks of intravenous ceftriaxone therapy. Conduit replacement was performed after appropriate antibiotic therapy with favourable course.
Klaudia Kosowskashick - One of the best experts on this subject based on the ideXlab platform.
-
activity of dx 619 compared to other agents against viridans group streptococci streptococcus bovis and Cardiobacterium hominis
Antimicrobial Agents and Chemotherapy, 2006Co-Authors: Klaudia Kosowskashick, Kathy Smith, Tatiana Bogdanovich, Lois M Ednie, Ronald N Jones, Peter C AppelbaumAbstract:Against 198 viridans group streptococci, 25 Streptococcus bovis strains, and 5 Cardiobacterium hominis strains, MICs of DX-619, a des-F(6)-quinolone, were between 0.004 and 0.25 microg/ml. These MICs were lower than those of other quinolones ( 32 microg/ml). Beta-lactam MICs were between < or = 0.008 and 16 microg/ml. Azithromycin resistance was found in most species, while most were telithromycin susceptible. Glycopeptides and linezolid were active against viridans group strains but inactive against C. hominis.
Mehdi Slim - One of the best experts on this subject based on the ideXlab platform.
-
a pediatric case of Cardiobacterium hominis endocarditis after right ventricular outflow tract reconstruction
Journal of Infectious Diseases and Therapy, 2015Co-Authors: Mehdi Slim, R Gribaa, Elies Neffati, Sana Ouali, F Remadi, Essia BoughzelaAbstract:Cardiobacterium hominis, a member of the HACEK group of organisms, is a rare cause of endocarditis and is even rarer in pediatric population. In this report, we present a case of infective endocarditis caused by C. hominis in a 16-year-old Tunisian girl who had undergone right ventricular outflow tract reconstruction using a Hancock® heterograft for double outlet right ventricle with pulmonary stenosis. Two weeks before admission, the patient suffered from worsened shortness of breath and fever. Tranthoracic echocardiography revealed right ventricular outflow tract stenosis and vegetation attached to the leaflet conduit. The Subsequent blood cultures grew Cardiobacterium hominis and the patient was treated successfully with 6 weeks of intravenous ceftriaxone therapy. Conduit replacement was performed after appropriate antibiotic therapy with favourable course.
Kathy Smith - One of the best experts on this subject based on the ideXlab platform.
-
activity of dx 619 compared to other agents against viridans group streptococci streptococcus bovis and Cardiobacterium hominis
Antimicrobial Agents and Chemotherapy, 2006Co-Authors: Klaudia Kosowskashick, Kathy Smith, Tatiana Bogdanovich, Lois M Ednie, Ronald N Jones, Peter C AppelbaumAbstract:Against 198 viridans group streptococci, 25 Streptococcus bovis strains, and 5 Cardiobacterium hominis strains, MICs of DX-619, a des-F(6)-quinolone, were between 0.004 and 0.25 microg/ml. These MICs were lower than those of other quinolones ( 32 microg/ml). Beta-lactam MICs were between < or = 0.008 and 16 microg/ml. Azithromycin resistance was found in most species, while most were telithromycin susceptible. Glycopeptides and linezolid were active against viridans group strains but inactive against C. hominis.